CLINICAL_TRIALS
trial_result
· 2012-08-23
Clinical Trial Update: A Study of the Long-term Safety of Sativex Use [Phase 3]
Summary
Long-term safety study update for Sativex in multiple sclerosis patients with spasticity (Phase 3; completed; results posted).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jazz Pharmaceuticals | Conditions: Multiple Sclerosis, Spasticity | Phase 3 | Status: COMPLETED | Results posted: 2012-08-23